<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
March 5, 1998 (February 27, 1998)
Commission File No. 0-11772
-------
NU-TECH BIO-MED, INC.
---------------------
(Exact name of registrant as specified in its charter)
Delaware 25-1411971
-------- ----------
(State or other jurisdiction of (IRS Employer Identification No.)
incorporation of organization)
476 Main Street, Suite 3-DFL, Wakefield, Rhode Island 02879
- ----------------------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (401) 789-9995
---------------------------
(Former name or former address, if changed since last report.)
Page 1 of 3
<PAGE> 2
ITEM 5. OTHER EVENTS
By letter dated February 27, 1998, received by the Company on March 2,
1998, the Company was advised by the NASDAQ Stock Market that the Company's
Common Stock was not in compliance with the new $1.00 minimum bid price
requirement for continued listing of securities on the NASDAQ SmallCap Market,
which became effective February 23, 1998, since the price for the Company's
Common Stock for the 30 consecutive trading days immediately preceding
effectiveness of the new rule was below $1.00.
In the letter, NASDAQ informed the Company that if the Common Stock does
not trade at $1.00 or above for 10 consecutive trading days at any time during
the 90-day period commencing on February 27, 1998, and ending on May 28, 1998,
NASDAQ will thereupon commence proceedings to delist the Common Stock from the
SmallCap Market.
Page 2 of 3
<PAGE> 3
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report on Form 8-K to be signed on its
behalf by the undersigned hereunto duly authorized.
NU-TECH BIO-MED, INC.
By: /s/ J. Marvin Feigenbaum
------------------------
J. Marvin Feigenbaum
Chairman of the Board,
President, Chief Executive
and Chief Financial Officer
Dated: March 5, 1998
Page 3 of 3
